Table of Contents:
Individual chapters are available for $25 each by sending an email to firstname.lastname@example.org. Nova will provide the chapter for your easy downloading or send it as an email attachment if you prefer.
Preface; The Emerging Role of High-Density Lipoprotein in the Management of Cardiovascular Disease (Peter P. Toth, University of Illinois School of Medicine)pp.1-28; Oxidized LDL: Role in Cardiovascular Risk and Disease (Paul Holvoet, University of Leuven, Belgium)pp.29-44; Effects of Therapy with LDL Apheresis in Patients with Familial Hypercholestrolemia – the Dresden Experience (U. Julius and C. Namokel, Universitätsklinikum Carl Gustav Carus Dresden, Germany)pp.45-62; HDL Cholesterol and CETP Inhibitors (Hisashi Shinkai, Central Pharmaceutical Research Institute, JT Inc.)pp.63-78; Differential Response of High Density Lipoprotein Cholesterol to Hypolipidemic Treatment (Genovefa D. Kolovou, Onassis Cardiac Surgery Center, Athens, Greece)pp.79-102; Hyperlipidemia and Immunosuppressive Therapy – Pitfalls of Post Transplantation Management (Marius Berman, Tel Aviv University, Israel)pp.103-130; Postprandial Lipemia and Atherosclerosis: Exercise and Omega 3 Fatty Acids: the Non Pharmaceutical Interventions (John Q. Zhang, University of Texas at San Antonio)pp.131-156; Lipid-lowering Drugs. Pharmacoepidemiological Studies of Prescription Patterns in General Practice (John Larsen, University of Southern Denmark)pp.157-186; The Cholesterol Lowering Effect of Plant Sterols (Elizabeth J. Brink and Henk F.J. Hendriks, TNO Nutrition and Food Research, The Netherlands)pp.187-214; Homecysteine and Cardiovascular Risk (Johann Auer et al., General Hospital Wels, Austria)pp.215-232; Infection, Dyslipidemia, and Early Atherosclerosis: Interaction and Causation (Petru Liuba, University Hospital Lund, Sweden)pp.233-254; Index.